Skip to content
Nephro Critical Care Society
  • Home
  • About
    • About Us
    • Our Journey
    • Vision, Mission & Objectives
    • Affiliations
  • Activities
    • Quiz OF The Week
    • Knowledge Sharing
    • Training Courses
    • Research
      • GLOBE RRT Survey
    • Literature
    • 5th Global Update In Nephro Critical Care POCUS IN NEPHRO CRITICAL CARE (PINC)
  • Blog
  • Media
    • Gallery
    • Videos
      • CRRT
      • AKI
      • Investigations & Biomarker
      • Fluid Therapy
      • Drug Dosing
      • Journal Scan
      • Other Extracorporeal Therapy
      • 5th Global Update In Nephro Critical Care POCUS IN NEPHRO CRITICAL CARE (PINC)
      • 5th Nephrocritical Care Review Course
  • Membership
    • Membership Benefits
    • All Members
    • Plus Members
  • My Account
    • Login
  • Contact Us
  • Home
  • About
    • About Us
    • Our Journey
    • Vision, Mission & Objectives
    • Affiliations
  • Activities
    • Quiz OF The Week
    • Knowledge Sharing
    • Training Courses
    • Research
      • GLOBE RRT Survey
    • Literature
    • 5th Global Update In Nephro Critical Care POCUS IN NEPHRO CRITICAL CARE (PINC)
  • Blog
  • Media
    • Gallery
    • Videos
      • CRRT
      • AKI
      • Investigations & Biomarker
      • Fluid Therapy
      • Drug Dosing
      • Journal Scan
      • Other Extracorporeal Therapy
      • 5th Global Update In Nephro Critical Care POCUS IN NEPHRO CRITICAL CARE (PINC)
      • 5th Nephrocritical Care Review Course
  • Membership
    • Membership Benefits
    • All Members
    • Plus Members
  • My Account
    • Login
  • Contact Us

QW55-October 2025

Question: Select each option to validate with explanations

Clinical Case Scenario : QA

A 70-year-old man with known decompensated alcoholic liver cirrhosis presents to the ICU.

History

  • One-day history of worsening confusion, reduced urine output, and refractory hypotension despite fluids.
  • Hypertension, type 2 diabetes mellitus.
  • No history of chronic kidney disease before this admission.

 

Vital Signs

  • HR: 104/min, BP: 84/60 mmHg (MAP 64 on norepinephrine infusion).
  • Temp: 38.7°C.
  • SpO₂: 94% on 4L O₂ via nasal cannula.
  • RR: 22/min.

 

Laboratory Findings

  • Serum Na⁺: 172 mmol/L
  • Serum osmolarity: 350 mOsm/kg
  • pH: 7.32, HCO₃⁻: 18 mmol/L
  • MAP: 64 mmHg on norepinephrine infusion

 

Question: Which of the following is the most appropriate way to use 3% NaCl during CRRT to safely manage this patient’s hypernatremia?
😭

Wrong Answer: A. Add 3% NaCl directly into the CRRT substitution/replacement fluid to match the patient’s serum sodium, thereby preventing rapid correction.

😉

Right Answer: B. Infuse 3% NaCl as a separate infusion running via a central line and titrate rate to counteract sodium removal during CRRT.

Explaination

The most dramatic symptoms of hypernatremia are witnessed when the increase in serum [Na+] has been either too large or too brisk. Chronic hypernatraemia is less symptomatic be- cause organic osmolytes (glutamine, glutamate, taurine and myo-inositol) enter brain cells and help restore normal brain volume.[1]
A rapid decrease in serum sodium, particularly in chronic situations when compensation has occurred, can lead to significant water shifts into brain cells and cerebral edema. The rate of correction should not exceed 10-12 mmol/day (0.5 mmol/h).[2]

● Option A: Adding 3% NaCl directly into CRRT fluids is not safe or reliable. Commercial solutions are designed with specific osmolarity and any additional risks instability and dosing errors.
● Option B: Correct. The preferred and controlled way to prevent rapid sodium drop is to run CRRT with standard solutions while giving a separate 3% NaCl infusion titrated to the net sodium balance target (to cap correction at ≤ 8–10 mmol/L per 24 hr).
● Option C: Increasing dialysate sodium with 3% NaCl is unsafe and unstandardized since bag modification alters osmotic stability and leads to unpredictable shifts.
● Option D: Deferring CRRT risks worsening acidosis, hyperkalemia, and fluid overload; hypernatremia is not an absolute contraindication but requires careful Na⁺ balance management.

😭

Wrong Answer: C. Increase dialysate sodium concentration by adding 3% NaCl into the dialysate bag and run CRRT at high efficiency to normalize sodium quickly.

😭

Wrong Answer: D. Withhold CRRT until serum sodium is below 155 mmol/L, then initiate standard prescription to avoid osmotic shifts.

Clinical Case Scenario: QB

The same patient is started on continuous renal replacement therapy (CRRT). On day 1, his laboratory results are:

  • Serum sodium: 172 mmol/L
  • Weight: 70 kg
  • CRRT prescription: CVVHDF with dialysate sodium concentration of 140 mmol/L, total effluent rate 25 mL/kg/hr
  • No ongoing free water losses (insensible losses balanced by replacement)

To buffer sodium loss, you decide to infuse 3% NaCl via a central line during CRRT.
(Assume distribution volume of Na = 0.6 × body weight, and [Na] in 3% NaCl = 513 mmol/L).

Question: What is the approximate rate (mL/hr) of 3% NaCl infusion required to limit the serum sodium drop to less than 10 mmol/L/day?
😭

Wrong Answer: A. 30 mL/hr

😭

Wrong Answer: B. 50 mL/hr

😉

Right Answer: C. 75 mL/hr. Infuse 3% NaCl at ~75 mL/hr as a separate central line infusion to buffer sodium losses during CRRT.

Explaination

● Serum sodium: 172 mmol/L
● Weight: 70 kg
● CRRT prescription: CVVHDF with dialysate Na⁺ concentration of 140 mmol/L, total effluent rate 25 mL/kg/hr
● No ongoing free water losses (insensible balanced by replacement)

You want to prevent a serum sodium fall >10 mmol/L in 24 hours. To buffer this, you decide to run a continuous 3% NaCl infusion via central line alongside CRRT.

Question: What is the approximate rate (mL/hr) of 3% NaCl infusion required to limit serum sodium drop to less than 10 mmol/L/day?
(Assume distribution volume of Na⁺ = 0.6 × body weight, and [Na⁺] in 3% NaCl = 513 mmol/L)
________________________________________
Stepwise Reasoning
TBW = 0.6 × 70 kg = 42 L
Effluent volume/day = 25 × 70 = 1750 mL/hr = ~42 L/day
Sodium lost/day = 172 × 42 = 7224 mmol
Sodium replaced via CRRT fluids = 140 × 42 = 5880 mmol
Net sodium loss = 7224 − 5880 = 1344 mmol/day
Allowed loss = 10 × 42 = 420 mmol/day
Required supplementation = 1344 − 420 = 924 mmol/day
Volume of 3% NaCl = 924 ÷ 513 ≈ 1.8 L/day ≈ 75 mL/hr

😭

Wrong Answer: D. 120 mL/hr

Reference:
1. Adrogué HJ, Madias NE: Hypernatremia. N Engl J Med 2000;342:1493–1499.
2. Overgaard-Steensen C, Ring T: Clinical review: practical approach to hyponatraemia and hypernatraemia in critically ill patients. Crit Care 2013;17:206–219.
3. Ostermann M, Dickie H, Tovey L, Treacher D: Management of sodium disorders during continuous haemofiltration. Crit Care 2010; 14:418–419.
4. https://crrtonline.com/conference/support/Protocols/CorrectionofhyperandhyponatraemiaNCP2015(1).pdf
This field is for validation purposes and should be left unchanged.
Nephro Critical Care Society

All rights reserved